Is the Sentinel Lymph Node Biopsy Safe and Accurate After Previous Surgery for Vulvar Squamous Cell Carcinoma? A Systematic Review
- 1Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples "Federico II", 80131 Naples, Italy.
- 2Department of Public Health, School of Medicine, University of Naples "Federico II", 80131 Naples, Italy.
- 3Obstetrics and Gynecology Unit, Villa Sofia Cervello Hospital, I.V.F. Public Center, University of Palermo, Via Trabucco, 180, 90146 Palermo, Italy.
- 4Clinic of Obstetrics and Gynecology Unit, Department of Medical Area (DMED), Santa Maria Della Misericordia Hospital, Azienda Sanitaria Friuli Centrale, 33100 Udine, Italy.
- 0Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples "Federico II", 80131 Naples, Italy.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Sentinel lymph node biopsy (SLNB) is a safe and accurate alternative to lymphadenectomy for vulvar squamous cell carcinoma (VSCC). This method is effective even for patients with recurrent VSCC, offering a viable option when lymphadenectomy is not feasible.
Area Of Science
- Gynecologic Oncology
- Surgical Pathology
- Oncology
Background
- Lymphadenectomy for vulvar carcinoma is associated with significant complications.
- Sentinel lymph node biopsy (SLNB) has emerged as a diagnostic alternative for early-stage vulvar squamous cell carcinoma (VSCC).
Purpose Of The Study
- To assess the feasibility, safety, accuracy, and oncological outcomes of SLNB after scar injection for VSCC.
- To evaluate the utility of repeat sentinel node procedures in patients with local vulvar recurrence.
Main Methods
- Systematic literature search conducted in major electronic databases (MEDLINE, EMBASE, Web of Science, PubMed, Cochrane Library) from 2010 to August 2024.
- Inclusion of English-language scientific publications only.
- Risk of bias assessment performed on included studies.
Main Results
- Five studies (four retrospective, one prospective) were included, reporting on patient characteristics, surgical details, morbidities, adjuvant therapy, recurrence, SLN detection, and oncological outcomes.
- Four studies compared scar-injection SLNB with tumor-injection SLNB.
- One study evaluated repeat SLNB for vulvar recurrence versus primary SLNB.
Conclusions
- Sentinel lymph node biopsy (SLNB) is a feasible and safe procedure for VSCC, including in patients with prior vulvar tumor excision.
- SLNB accurately determines nodal status in patients with VSCC who cannot or will not undergo lymphadenectomy.
- Repeat SLNB is a viable option for patients experiencing local vulvar recurrence.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

